BioMarin Pharmaceuticals
BMRN
BMRN
537 hedge funds and large institutions have $12B invested in BioMarin Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 90 funds opening new positions, 199 increasing their positions, 182 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less first-time investments, than exits
New positions opened: 90 | Existing positions closed: 92
3% less capital invested
Capital invested by funds: $12.4B → $12B (-$383M)
2% less funds holding
Funds holding: 548 → 537 (-11)
Holders
537
Holding in Top 10
7
Calls
$141M
Puts
$128M
Top Buyers
| 1 | +$164M | |
| 2 | +$65.8M | |
| 3 | +$58.5M | |
| 4 |
Dodge & Cox
San Francisco,
California
|
+$55.7M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$49.8M |
Top Sellers
| 1 | -$83.2M | |
| 2 | -$81.8M | |
| 3 | -$53.7M | |
| 4 |
Neuberger Berman Group
New York
|
-$52.8M |
| 5 |
Primecap Management
Pasadena,
California
|
-$44.6M |